Private Advisor Group LLC decreased its stake in The Clorox Company (NYSE:CLX – Get Rating) by 3.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 31,236 shares of the company's stock after selling 1,235 shares during the quarter. Private Advisor Group LLC's holdings in Clorox were worth $1,452,614,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Federated Hermes Inc. lifted its stake in shares of Clorox by 86.2% during the 2nd quarter. Federated Hermes Inc. now owns 1,945,898 shares of the company's stock worth $274,332,000 after acquiring an additional 901,040 shares during the last quarter. State Street Corp lifted its stake in shares of Clorox by 9.6% during the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company's stock worth $1,255,721,000 after acquiring an additional 778,269 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Clorox by 5.6% during the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock worth $1,407,673,000 after acquiring an additional 580,982 shares during the last quarter. Two Sigma Investments LP raised its position in Clorox by 4,186.6% during the 3rd quarter. Two Sigma Investments LP now owns 303,622 shares of the company's stock valued at $38,982,000 after purchasing an additional 296,539 shares in the last quarter. Finally, Invesco Ltd. raised its position in Clorox by 38.2% during the 1st quarter. Invesco Ltd. now owns 1,051,679 shares of the company's stock valued at $146,216,000 after purchasing an additional 290,833 shares in the last quarter. Hedge funds and other institutional investors own 79.12% of the company's stock.

Clorox Stock Up 1.9 %

Shares of CLX stock opened at $157.50 on Monday. The Clorox Company has a 1-year low of $120.50 and a 1-year high of $160.59. The stock's fifty day moving average price is $150.56 and its 200 day moving average price is $144.95. The company has a debt-to-equity ratio of 5.04, a current ratio of 0.86 and a quick ratio of 0.47. The company has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a price-to-earnings-growth ratio of 3.12 and a beta of 0.29.

Clorox (NYSE:CLX – Get Rating) last announced its earnings results on Thursday, February 2nd. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.32. Clorox had a return on equity of 89.97% and a net margin of 6.16%. The firm had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.66 billion. During the same period in the previous year, the business earned $0.66 EPS. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 4.23 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be paid a dividend of $1.18 per share. The ex-dividend date of this dividend is Tuesday, April 25th. This represents a $4.72 annualized dividend and a yield of 3.00%. Clorox's dividend payout ratio (DPR) is 134.86%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research report on Friday, January 13th. Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $152.00 to $147.00 in a research report on Monday, March 20th. StockNews.com initiated coverage on Clorox in a research report on Thursday, March 16th. They set a "hold" rating for the company. UBS Group boosted their price target on Clorox from $129.00 to $140.00 in a research report on Friday, February 3rd. Finally, Raymond James boosted their price target on Clorox from $160.00 to $165.00 and gave the stock an "outperform" rating in a research report on Friday, February 3rd. Seven analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $141.00.

Clorox Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Recommended Stories

• Get a free copy of the StockNews.com research report on Clorox (CLX)
• MarketBeat Week in Review – 3/20 – 3/24
• Dividend King Genuine Parts Company Upgraded On Profit Guidance
• The Bottom Is In For Accenture
• 11 Best Consumer Discretionary Stocks of 2023
• 5 Best Dividend Capture Stocks

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.